Author:
Croci Leonardo,Trezzi Michele,Allegri Maria Pia,Carli Tiziana,Chigiotti Silvia,Riccardi Maria Piera,Ricciardi Barbara,Toti Mario,Nencioni Cesira
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference9 articles.
1. Public Health Service Task Force (2011) Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. http://AIDSinfo.nih.gov . Accessed 18 October 2011
2. Public Health Service Task Force (2011) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. http://AIDSinfo.nih.gov . Accessed 18 October 2011
3. Fabbiani M, Di Giambenedetto S, Bracciale L, Bacarelli A, Ragazzoni E, Cauda R, Navarra P, De Luca A (2009) Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice. J Antimicrob Chemother 64:109–117. doi: 10.1093/jac/dkp132
4. McKeown DA, Rosenvinge M, Donaghy S, Sharland M, Holt DW, Cormack I, Hay P, Sadiq ST (2010) High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women. AIDS 24(15):2416–2418. doi: 10.1097/QAD. 0b013e32833d8a50
5. Jaworsky D, Thompson C, Yudin MH, Bitnun A, Brophy J, Samson L, Antoniou T, Loutfy MR (2010) Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases. Antivir Ther 15:677–680. doi: 10.3851/IMP1558
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献